Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia

Research output: Contribution to journalJournal articleResearchpeer-review

  1. GPIHBP1 autoantibody syndrome during interferon β1a treatment

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. An enzyme-linked immunosorbent assay for measuring GPIHBP1 levels in human plasma or serum

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Effect of tofacitinib on lipid levels and lipid-related parameters in patients with moderate to severe psoriasis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Pathogenic classification of LPL gene variants reported to be associated with LPL deficiency

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism

    Research output: Contribution to journalReviewResearchpeer-review

  2. Evolution and Medical Significance of LU Domain-Containing Proteins

    Research output: Contribution to journalReviewResearchpeer-review

  3. The PCNA interaction motifs revisited: thinking outside the PIP-box

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Did evolution create a flexible ligand-binding cavity in the urokinase receptor through deletion of a plesiotypic disulfide bond?

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Xuchen Hu
  • Geesje M Dallinga-Thie
  • G Kees Hovingh
  • Sandy Y Chang
  • Norma P Sandoval
  • Tiffany Ly P Dang
  • Isamu Fukamachi
  • Kazuya Miyashita
  • Katsuyuki Nakajima
  • Masami Murakami
  • Loren G Fong
  • Michael Ploug
  • Stephen G Young
  • Anne P Beigneux
View graph of relations

BACKGROUND: GPIHBP1, a glycolipid-anchored protein of capillary endothelial cells, binds lipoprotein lipase (LPL) in the interstitial spaces and transports it to the capillary lumen. GPIHBP1 deficiency prevents LPL from reaching the capillary lumen, resulting in low intravascular LPL levels, impaired intravascular triglyceride processing, and severe hypertriglyceridemia (chylomicronemia). A recent study showed that some cases of hypertriglyceridemia are caused by autoantibodies against GPIHBP1 ("GPIHBP1 autoantibody syndrome").

OBJECTIVE: Our objective was to gain additional insights into the frequency of the GPIHBP1 autoantibody syndrome in patients with unexplained chylomicronemia.

METHODS: We used enzyme-linked immunosorbent assays to screen for GPIHBP1 autoantibodies in 33 patients with unexplained chylomicronemia and then used Western blots and immunocytochemistry studies to characterize the GPIHBP1 autoantibodies.

RESULTS: The plasma of 1 patient, a 36-year-old man with severe hypertriglyceridemia, contained GPIHBP1 autoantibodies. The autoantibodies, which were easily detectable by Western blot, blocked the ability of GPIHBP1 to bind LPL. The plasma levels of LPL mass and activity were low. The patient had no history of autoimmune disease, but his plasma was positive for antinuclear antibodies.

CONCLUSIONS: One of 33 patients with unexplained chylomicronemia had the GPIHBP1 autoantibody syndrome. Additional studies in large lipid clinics will be helpful for better defining the frequency of this syndrome and for exploring the best strategies for treatment.

Original languageEnglish
JournalJournal of Clinical Lipidology
Volume11
Issue number4
Pages (from-to)964-971
Number of pages8
ISSN1933-2874
DOIs
Publication statusPublished - 2 Jul 2017

    Research areas

  • Journal Article

ID: 52425654